Vestibulocerebellar syndrome

Last updated
Vestibulocerebellar syndrome
Gehirn, basal - beschriftet lat.svg
Basal view of the human brain including the cerebellum

Vestibulocerebellar syndrome, also known as vestibulocerebellar ataxia, is a progressive neurological disorder that causes a variety of medical problems. Initially symptoms present as periodic attacks of abnormal eye movements but may intensify to longer-lasting motor incapacity. The disorder has been localized to the vestibulocerebellum, specifically the flocculonodular lobe. [1] Symptoms of vestibulocerebellar syndrome may appear in early childhood but the full onset of neurological symptoms including nystagmus (involuntary eye movement), ataxia (loss of voluntary muscle coordination), and tinnitus (perception of sound in the absence of external stimulation) does not occur until early adulthood. [2] To date, vestibulocerebellar syndrome has only been identified in three families but has affected multiple generations within them. Based on the familial pedigrees it has been characterized as an autosomal dominant disorder, although the exact genetic locus has not been identified. [2] [3] It has been found to be genetically distinct from other seemingly similar forms of neurological syndromes such as episodic ataxia types 1 and 2. Due to its rarity, however, little is known about specific details of the pathology or long-term treatment options. [2] There is currently no cure for vestibulocerebellar syndrome, although some drug therapies have been effective in alleviating particular symptoms of the disorder.

Contents

Anterior view of the cerebellum showing the flocculus and nodulus of the vestibulocerebellum. Gray703.png
Anterior view of the cerebellum showing the flocculus and nodulus of the vestibulocerebellum.

Symptoms

The symptoms of vestibulocerebellar syndrome vary among patients but are typically a unique combination of ocular abnormalities including nystagmus, poor or absent smooth pursuit (ability of the eyes to follow a moving object), strabismus (misalignment of the eyes), diplopia (double vision), oscillopsia (the sensation that stationary objects in the visual field are oscillating) and abnormal vestibulo-ocular reflex (reflex eye adjustment to stabilize gaze during head movement). [4] Gaze-paretic nystagmus, one of the most common symptoms among patients results in poor gaze-holding due to neuron integrator dysfunction. Rebound nystagmus is also frequently found in conjunction with gaze-paretic nystagmus and is characteristic of cerebellar malfunction. [5] These abnormal eye movements are often the earliest indicators of the disorder and may appear during childhood. The time of full onset of symptoms, including motor abnormalities, ranges from age 30 to age 60. Initially, symptoms present as isolated episodic attacks but occur at increasing frequency over time and may eventually become a permanent condition. [2] In conjunction with eye abnormalities patients also present with periodic attacks of vertigo, tinnitus, and ataxia that are associated with sudden changes in head position. [3] Attacks were seen to vary in duration from a few minutes to months in different individuals and were often accompanied by nausea and vomiting. [6]

During a typical attack, patients reported having ataxic gait with a tendency to fall to either side while lacking the ability to walk heel-to-toe. [6] With more severe attacks, patients had to sit down due to extreme unsteadiness. Fine motor abilities, such as writing and buttoning clothes, became impaired during an attack. However, speech remained unaffected. Attacks did not cause a loss of consciousness nor did they disturb mental activity. [6] Once the attack ended, oscillopsia faded and the intensity of nystagmus decreased. [5] Although these attacks are similar to episodic ataxia, patients with vestibulocerebellar syndrome do not completely lose motor control in arms and legs or experience dysarthria (poor speech articulation), as patients with episodic ataxia do. [7] The disturbances to vestibular function during periodic attacks are the primary distinction between vestibulocerebellar syndrome and other similar neurological syndromes. These conditions do not consistently cause the symptoms of dizziness and ocular impairment that have been localized to the vestibulocerebellum, leading researchers to characterize vestibulocerebellar syndrome as a distinct disorder.

Causes

The mechanism of the vestibulo-ocular reflex. Simple vestibulo-ocular reflex.PNG
The mechanism of the vestibulo-ocular reflex.

Vestibulocerebellar syndrome is caused by a failure in the function of the flocculus of the vestibulocerebellum, one of the three main divisions of the cerebellum. Generally, the cerebellum is responsible for regulating motor commands. The main function of the vestibulocerebellum is to receive sensory input from the vestibular nuclei in the brainstem and to regulate equilibrium, balance, and the vestibulo-ocular reflex accordingly. The vestibulo-ocular reflex, one of the primary areas affected by vestibulocerebellar syndrome, is responsible for counterrotating the eyes in response to head movements. This allows gaze to stay fixed on a specific point. A failure in this reflex results in a variety of eye movement abnormalities, such as those exhibited in vestibulocerebellar syndrome. [8]

Vestibulocerebellar syndrome has been categorized as an autosomal dominant neurological disorder although the specific effect on the vestibulocerebellum is unknown. It is possible that inheritance causes abnormalities in either the flocculus or in structures that project into the flocculus to maintain stability of the retinal image of stationary or moving visual objects. [4] Pathological symptoms of the disorder may appear within the first 1–2 years of life although time of onset varies greatly among patients. The severity of symptoms typically progresses with age. The exact cause of the disorder and its pathogenic effect on the flocculus is unknown. A single genetic locus, however, critical in early eye movement control pathways on chromosome 13q31-q33 has been discovered. This locus may be involved in some of the ocular abnormalities that occur in affected individuals. Chromosome 13q31-q33, however, has not been seen to correspond to any known existing gene or locus responsible for congenital nystagmus, one of the primary symptoms of vestibulocerebellar syndrome, or for better-understood cerebellar ataxias. [4]

Vestibulocerebellar syndrome shares clinical similarities with autosomal dominant ataxias, particularly episodic ataxia types 1 and 2. These similarities include gaze-evoked and rebound nystagmus and vertigo. Furthermore, the symptoms appear to progress over time. [9] The molecular basis of many of these other disorders has been thoroughly established and in some cases a genetic locus has been identified. Despite the similarities between symptoms of episodic ataxia and vestibulocerebellar syndrome, studies of affected individuals have shown that the disorder is genetically distinct from these other similar neurological conditions. To date, the molecular basis of vestibulocerebellar syndrome remains undefined. [2]

Diagnosis

Management

Attacks of vestibulocerebellar syndrome may be triggered by a sudden change in head position, fatigue, or by being in an environment of fast-moving objects. These attacks may be alleviated by lying quietly with eyes closed for fifteen to thirty minutes. Lying down stabilizes the head in a fixed position while closing the eyes removes the unstable sensory input responsible for the dizziness. Treatment is presently focused on addressing specific symptoms to alleviate the nausea that often accompanies attacks and to make daily life more manageable. There have been very few studies on the effectiveness of drugs that are used for the management of other ataxias on vestibulocerebellar syndrome. [2] Trials with acetazolamide achieved some success, while amitriptyline hydrochloride was unsuccessful. [2] [3] Acetazolamide therapy proved effective in treating episodic vertigo. In trials of patients who have vestibulocerebellar syndrome, acetazolamide either eliminated or significantly decreased the frequency and severity of vertigo episodes. [10] Dramamine (Dimenhydrinate) and antihistamine drugs have also been helpful in decreasing the frequency and severity of attacks. [6]

Prognosis

There is currently[ when? ] no cure for vestibulocerebellar ataxia. [10] When a diagnosis is made in early adulthood on the basis of periodic attacks of vertigo, diplopia, and tinnitus, one can expect recurrent episodes of progressive ataxia later in life. [5] In order to confirm the presence of vestibulocerebellar ataxia, a family examination demonstrating similar symptoms is critical in order to prevent a misdiagnosis. [7] A person with this disorder will find daily tasks increasingly difficult as progressive ataxia develops. Attacks can eventually increase with more frequency and become a permanent condition.

Origin and history

Periodic vestibulocerebellar syndrome has been discovered in several generations of three families with genetic ties to Johnston County, North Carolina. [3] The first was discovered in 1963 by T.W. Farmer and a group of researchers who studied and published a paper on the syndrome. The second case was studied and published in 1984 by Vance et al. [6] [11] Individuals in these families were categorized as affected if they exhibited one form of primary criteria (ataxia, marked loss of smooth pursuit, gaze-evoked nystagmus, and impaired vestibulo-ocular reflex suppression) and at least one secondary criteria (mild loss of smooth pursuit, mild gaze-evoked nystagmus, and esophoria or esotropia). [2]

Historically vestibulocerebellar syndrome has been difficult to classify because of the variation in symptoms, severity, and time of onset. During the earlier stages of attacks, members of the third family classified as having vestibulocerebellar syndrome were unaware that other family members experienced the same debilitating symptoms. It was not until after researchers, Vance et al. examined the family history that a diagnosis was made characterizing three generations of the family as affected by vestibulocerebellar syndrome. [11] In addition to these variations, vestibulocerebellar syndrome is also difficult to distinguish from other neurological disorders that result in similar degenerative symptoms such as ataxia and multiple sclerosis. [7]

Research directions

There has been no gene or locus determined to cause vestibulocerebellar syndrome. Genes involved in central nervous system development or maintenance, however, may be considered as candidate genes. As of 2003, research is being done to investigate the potential role of these genes in vestibulocerebellar syndrome. Some possible candidate genes include, SOX21, ZIC2, and TYRP2. Genes that are part of the SOX family are expressed in the developing embryonic brain. Although no individuals have presented with brain abnormalities, it is possible that one of these candidate genes could have a more minor mutation, leading to the symptoms of vestibulocerebellar syndrome. TYRP2, for example, is important in the development of correct pigmentation; general and ocular albinism is associated with nystagmus. Since there is no anatomical correlations with this syndrome, failure of flocculus function is thought to be the cause of the eye movement abnormalities. Researchers surmise, therefore, that there exists a gene critical to establishing early eye movement control pathways. [4]

Related Research Articles

<span class="mw-page-title-main">Medial longitudinal fasciculus</span> Nerve tracts in the brainstem

The medial longitudinal fasciculus (MLF) is an area of crossed over tracts, on each side of the brainstem. These bundles of axons are situated near the midline of the brainstem. They are made up of both ascending and descending fibers that arise from a number of sources and terminate in different areas, including the superior colliculus, the vestibular nuclei, and the cerebellum. It contains the interstitial nucleus of Cajal, responsible for oculomotor control, head posture, and vertical eye movement.

<span class="mw-page-title-main">Aniridia</span> Absence of the iris, usually involving both eyes

Aniridia is the absence of the iris, a muscular structure that opens and closes the pupil to allow light into the eye. It is also responsible for eye color. Without it, the central eye appears all black. It can be congenital, in which both eyes are usually involved, or caused by a penetrant injury. Isolated aniridia is a congenital disorder that is not limited to a defect in iris development, but is a panocular condition with macular and optic nerve hypoplasia, cataract, and corneal changes. Vision may be severely compromised and the disorder is frequently associated with some ocular complications: nystagmus, amblyopia, buphthalmos, and cataract. Aniridia in some individuals occurs as part of a syndrome, such as WAGR syndrome, or Gillespie syndrome.

Oscillopsia is a visual disturbance in which objects in the visual field appear to oscillate. The severity of the effect may range from a mild blurring to rapid and periodic jumping. Oscillopsia is an incapacitating condition experienced by many patients with neurological disorders. It may be the result of ocular instability occurring after the oculomotor system is affected, no longer holding images steady on the retina. A change in the magnitude of the vestibulo-ocular reflex due to vestibular disease can also lead to oscillopsia during rapid head movements. Oscillopsia may also be caused by involuntary eye movements such as nystagmus, or impaired coordination in the visual cortex and is one of the symptoms of superior canal dehiscence syndrome. Those affected may experience dizziness and nausea. Oscillopsia can also be used as a quantitative test to document aminoglycoside toxicity. Permanent oscillopsia can arise from an impairment of the ocular system that serves to maintain ocular stability. Paroxysmal oscillopsia can be due to an abnormal hyperactivity in the peripheral ocular or vestibular system.

<span class="mw-page-title-main">Electronystagmography</span>

Electronystagmography (ENG) is a diagnostic test to record involuntary movements of the eye caused by a condition known as nystagmus. It can also be used to diagnose the cause of vertigo, dizziness or balance dysfunction by testing the vestibular system. Electronystagmography is used to assess voluntary and involuntary eye movements. It evaluates the cochlear nerve and the oculomotor nerve. The ENG can be used to determine the origin of various eye and ear disorders.

<span class="mw-page-title-main">Spinocerebellar ataxia</span> Medical condition

Spinocerebellar ataxia (SCA) is a progressive, degenerative, genetic disease with multiple types, each of which could be considered a neurological condition in its own right. An estimated 150,000 people in the United States have a diagnosis of spinocerebellar ataxia at any given time. SCA is hereditary, progressive, degenerative, and often fatal. There is no known effective treatment or cure. SCA can affect anyone of any age. The disease is caused by either a recessive or dominant gene. In many cases people are not aware that they carry a relevant gene until they have children who begin to show signs of having the disorder.

<span class="mw-page-title-main">Flocculus</span>

The flocculus is a small lobe of the cerebellum at the posterior border of the middle cerebellar peduncle anterior to the biventer lobule. Like other parts of the cerebellum, the flocculus is involved in motor control. It is an essential part of the vestibulo-ocular reflex, and aids in the learning of basic motor skills in the brain.

<span class="mw-page-title-main">Behr syndrome</span> Medical condition

Behr syndrome is characterized by the association of early-onset optic atrophy with spinocerebellar degeneration resulting in ataxia, pyramidal signs, peripheral neuropathy and developmental delay.

<span class="mw-page-title-main">Hermansky–Pudlak syndrome</span> Medical condition

Heřmanský–Pudlák syndrome is an extremely rare autosomal recessive disorder which results in oculocutaneous albinism, bleeding problems due to a platelet abnormality, and storage of an abnormal fat-protein compound. It is thought to affect around 1 in 500,000 people worldwide, with a significantly higher occurrence in Puerto Ricans, with a prevalence of 1 in 1800. Many of the clinical research studies on the disease have been conducted in Puerto Rico.

Cerebellar ataxia is a form of ataxia originating in the cerebellum. Non-progressive congenital ataxia (NPCA) is a classical presentation of cerebral ataxias.

Alternating hemiplegia of childhood (AHC) is an ultra-rare neurological disorder named for the transient episodes, often referred to as "attacks", of hemiplegia that those with the condition experience. It typically presents before the age of 18 months. These hemiplegic attacks can cause anything from mild weakness to complete paralysis on one or both sides of the body, and they can vary greatly in duration. Attacks may also alternate from one side of the body to the other, or alternate between affecting one or both sides during a single attack. Besides hemiplegia, symptoms of the disorder include an extremely broad range of neurological and developmental impairments which are not well understood. Normally, hemiplegia and other associated symptoms cease completely with sleep, but they may recur upon waking.

Episodic ataxia (EA) is an autosomal dominant disorder characterized by sporadic bouts of ataxia with or without myokymia. There are seven types recognized but the majority are due to two recognized entities. Ataxia can be provoked by psychological stress or startle, or heavy exertion, including exercise. Symptoms can first appear in infancy. There are at least six loci for EA, of which 4 are known genes. Some patients with EA also have migraine or progressive cerebellar degenerative disorders, symptomatic of either familial hemiplegic migraine or spinocerebellar ataxia. Some patients respond to acetazolamide though others do not.

<span class="mw-page-title-main">Nystagmus</span> Dysfunction of eye movement

Nystagmus is a condition of involuntary eye movement. People can be born with it but more commonly acquire it in infancy or later in life. In many cases it may result in reduced or limited vision.

<span class="mw-page-title-main">Gillespie syndrome</span> Medical condition

Gillespie syndrome, also called aniridia, cerebellar ataxia and mental deficiency, is a rare genetic disorder. The disorder is characterized by partial aniridia, ataxia, and, in most cases, intellectual disability. It is heterogeneous, inherited in either an autosomal dominant or autosomal recessive manner. Gillespie syndrome was first described by American ophthalmologist Fredrick Gillespie in 1965.

Vertiginous epilepsy is infrequently the first symptom of a seizure, characterized by a feeling of vertigo. When it occurs, there is a sensation of rotation or movement that lasts for a few seconds before full seizure activity. While the specific causes of this disease are speculative there are several methods for diagnosis, the most important being the patient's recall of episodes. Most times, those diagnosed with vertiginous seizures are left to self-manage their symptoms or are able to use anti-epileptic medication to dampen the severity of their symptoms.

<span class="mw-page-title-main">Autosomal recessive cerebellar ataxia type 1</span> Hereditary ataxia that has material basis in autosomal recessive inheritance

Autosomal recessive cerebellar ataxia type 1 (ARCA1) is a condition characterized by progressive problems with movement. Signs and symptoms of the disorder first appear in early to mid-adulthood. People with this condition initially experience impaired speech (dysarthria), problems with coordination and balance (ataxia), or both. They may also have difficulty with movements that involve judging distance or scale (dysmetria). Other features of ARCA1 include abnormal eye movements (nystagmus) and problems following the movements of objects with their eyes. The movement problems are slowly progressive, often resulting in the need for a cane, walker, or wheelchair.

Oculomotor apraxia (OMA) is the absence or defect of controlled, voluntary, and purposeful eye movement. It was first described in 1952 by the American ophthalmologist David Glendenning Cogan. People with this condition have difficulty moving their eyes horizontally and moving them quickly. The main difficulty is in saccade initiation, but there is also impaired cancellation of the vestibulo-ocular reflex. Patients have to turn their head in order to compensate for the lack of eye movement initiation in order to follow an object or see objects in their peripheral vision, but they often exceed their target. There is controversy regarding whether OMA should be considered an apraxia, since apraxia is the inability to perform a learned or skilled motor action to command, and saccade initiation is neither a learned nor a skilled action.

Ocular albinism late onset sensorineural deafness (OASD) is a rare, X-linked recessive disease characterized by intense visual impairments, reduced retinal pigments, translucent pale-blue irises and moderately severe hearing loss from adolescence to middle-age. It is a subtype of Ocular Albinism (OA) that is linked to Ocular albinism type I (OA1). OA1 is the most common form of ocular albinism, affecting at least 1/60,000 males.

<span class="mw-page-title-main">Cerebellar ataxia, neuropathy, vestibular areflexia syndrome</span> Medical condition

Cerebellar Ataxia with Neuropathy and Vestibular Areflexia Syndrome (CANVAS) is an autosomal recessive late-onset heredodegenerative multisystem neurological disease. The symptoms include poor balance and difficulty walking. Chronic cough and difficulty swallowing may also be present. Clinical findings include ataxia, sensory neuropathy, and absence of the vestibulo–ocular reflex. The syndrome was initially described in 2004. In 2019, the cause was identified as biallelic pentanucleotide expansion in the RFC1 gene.

Autosomal dominant cerebellar ataxia, deafness, and narcolepsy (ADCADN) is a rare progressive genetic disorder that primarily affects the nervous system and is characterized by sensorineural hearing loss, narcolepsy with cataplexy, and dementia later in life. People with this disorder usually start showing symptoms when they are in their early-mid adulthoods. It is a type of autosomal dominant cerebellar ataxia.

CAPOS syndrome is a rare genetic neurological disorder which is characterized by abnormalities of the feet, eyes and brain which affect their normal function. These symptoms occur episodically when a fever-related infection is present within the body. The name is an acronym for "cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss".

References

  1. ↑ Theunissen EJ, Huygen PL, Verhagen WI (February 1989). "Familial vestibulocerebellar dysfunction: a new syndrome?". Journal of the Neurological Sciences . 89 (2–3): 149–55. doi:10.1016/0022-510x(89)90016-6. PMID   2926446. S2CID   31498395.
  2. 1 2 3 4 5 6 7 8 Damji KF, Allingham RR, Pollock SC, et al. (April 1996). "Periodic vestibulocerebellar ataxia, an autosomal dominant ataxia with defective smooth pursuit, is genetically distinct from other autosomal dominant ataxias". Archives of Neurology . 53 (4): 338–44. doi:10.1001/archneur.1996.00550040074016. PMID   8929156.
  3. 1 2 3 4 Small KW, Pollock SC, Vance JM, Stajich JM, Pericak-Vance M (June 1996). "Ocular motility in North Carolina autosomal dominant ataxia". J Neuroophthalmol. 16 (2): 91–5. doi: 10.1097/00041327-199606000-00002 . PMID   8797163. S2CID   39897382.
  4. 1 2 3 4 Ragge NK, Hartley C, Dearlove AM, Walker J, Russell-Eggitt I, Harris CM (January 2003). "Familial vestibulocerebellar disorder maps to chromosome 13q31-q33: a new nystagmus locus". J. Med. Genet. 40 (1): 37–41. doi:10.1136/jmg.40.1.37. PMC   1735258 . PMID   12525540.
  5. 1 2 3 Harris CM, Walker J, Shawkat F, Wilson J, Russell-Eggitt I (June 1993). "Eye movements in a familial vestibulocerebellar disorder". Neuropediatrics. 24 (3): 117–22. doi:10.1055/s-2008-1071526. PMID   8355816. S2CID   19694620.
  6. 1 2 3 4 5 FARMER TW, MUSTIAN VM (May 1963). "Vestibulocerebellar ataxia. A newly defined hereditary syndrome with periodic manifestations". Arch. Neurol. 8: 471–80. doi:10.1001/archneur.1963.00460050021002. PMID   13944410.
  7. 1 2 3 Farris BK, Smith JL, Ayyar DR (October 1986). "Neuro-ophthalmologic findings in vestibulocerebellar ataxia". Archives of Neurology . 43 (10): 1050–3. doi:10.1001/archneur.1986.00520100056015. PMID   3489454.
  8. ↑ Purves, Dale. Neuroscience. 4th ed. Sunderland, MA: Sinauer, 2008.
  9. ↑ Jen J, Kim GW, Baloh RW (January 2004). "Clinical spectrum of episodic ataxia type 2". Neurology. 62 (1): 17–22. doi:10.1212/01.wnl.0000101675.61074.50. PMID   14718690. S2CID   28147381.
  10. 1 2 Baloh RW, Winder A (March 1991). "Acetazolamide-responsive vestibulocerebellar syndrome: clinical and oculographic features". Neurology . 41 (3): 429–33. doi:10.1212/wnl.41.3.429. PMID   2006014. S2CID   45489324.
  11. 1 2 Vance, J. M., M. A. Pericak-Vance, C. S. Payne, J. T. Coin, and C. W. Olanow. "Linkage and Genetic Analysis in Adult Onset Periodic Vestibulo-Cerebellar Ataxia: Report of a New Family." American Journal of Human Genetics 36 (1984): 78S
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.